UCT4B, a new antitumor antibiotic with topoisomerase II mediated DNA cleavage activity.

UOSAKI YOUICHI, KAWADA SHO-ZOU, NAKANO HIROFUMI, SAITOH YUTAKA, SANO HIROSHI

doi:10.7164/antibiotics.46.235

UCT4B, a new antitumor antibiotic with topoisomerase II mediated DNA cleavage activity.

DOI PubMed 被引用文献1件

UOSAKI YOUICHI

Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
KAWADA SHO-ZOU

Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd. Technical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
NAKANO HIROFUMI

Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
SAITOH YUTAKA

Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
SANO HIROSHI

Tokyo Research Laboratories, Kyowa Hakko Kogyo Co., Ltd. Shimizu Institute, Marine Biotechnology Institute Co., Ltd.

書誌事項

タイトル別名

STRUCTURE DETERMINATION

この論文をさがす

CiNii Books

説明

The relative stereo structure of UCT4B was determined by means of chemical derivatization and spectral analysis, in relation to known antitumor antibiotics terpentecin, which was simultaneously produced with UCT4B by Streptomyces sp.